Carmichael Hill & Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,550
| Closed | -$11.7K | – | 708 |
|
|
2023
Q2 | $11.7K | Hold |
1,550
| – | – | 0.01% | 456 |
|
|
2023
Q1 | $13.7K | Hold |
1,550
| – | – | 0.01% | 427 |
|
|
2022
Q4 | $14.1K | Sell |
1,550
-675
| -30% | -$6.16K | 0.01% | 410 |
|
|
2022
Q3 | $18K | Hold |
2,225
| – | – | 0.01% | 408 |
|
|
2022
Q2 | $17K | Hold |
2,225
| – | – | 0.01% | 405 |
|
|
2022
Q1 | $21K | Hold |
2,225
| – | – | 0.01% | 398 |
|
|
2021
Q4 | $18K | Hold |
2,225
| – | – | 0.01% | 424 |
|
|
2021
Q3 | $22K | Buy |
2,225
+675
| +44% | +$6.67K | 0.01% | 397 |
|
|
2021
Q2 | $15K | Hold |
1,550
| – | – | 0.01% | 441 |
|
|
2021
Q1 | $18K | Hold |
1,550
| – | – | 0.01% | 410 |
|
|
2020
Q4 | $15K | Hold |
1,550
| – | – | 0.01% | 426 |
|
|
2020
Q3 | $14K | Hold |
1,550
| – | – | 0.01% | 400 |
|
|
2020
Q2 | $19K | Hold |
1,550
| – | – | 0.01% | 354 |
|
|
2020
Q1 | $14K | Hold |
1,550
| – | – | 0.01% | 353 |
|
|
2019
Q4 | $15K | Buy |
+1,550
| New | +$15K | 0.01% | 373 |
|